Truist Financial Raises Astrana Health (NASDAQ:ASTH) Price Target to $38.00

Astrana Health (NASDAQ:ASTH) had its price target upped by Truist Financial from $37.00 to $38.00 in a report released on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s price objective would indicate a potential upside of 57.03% from the company’s current price.

A number of other brokerages have also recently commented on ASTH. Zacks Research upgraded Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday. BTIG Research cut their price target on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating on the stock in a research note on Monday, February 2nd. Barclays lowered their price objective on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research note on Monday, November 24th. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a report on Monday, December 29th. Finally, Needham & Company LLC initiated coverage on shares of Astrana Health in a research note on Friday, December 12th. They set a “buy” rating and a $28.00 target price on the stock. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $34.00.

Astrana Health Trading Up 4.1%

Astrana Health stock traded up $0.95 during trading on Friday, hitting $24.20. The company had a trading volume of 203,099 shares, compared to its average volume of 566,654. The stock has a market cap of $1.36 billion, a price-to-earnings ratio of 52.32 and a beta of 0.91. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.25. Astrana Health has a 1-year low of $18.08 and a 1-year high of $34.80. The company’s 50 day simple moving average is $23.48 and its 200-day simple moving average is $26.03.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Monday, March 2nd. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.15 by $0.39. Astrana Health had a return on equity of 5.59% and a net margin of 0.71%.The business had revenue of $950.53 million during the quarter, compared to analyst estimates of $930.46 million. During the same period last year, the business posted ($0.15) earnings per share. The company’s quarterly revenue was up 42.9% on a year-over-year basis. As a group, analysts expect that Astrana Health will post 1.15 EPS for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Signaturefd LLC boosted its holdings in shares of Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after buying an additional 388 shares in the last quarter. GAMMA Investing LLC raised its stake in Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after acquiring an additional 871 shares in the last quarter. Strs Ohio acquired a new position in Astrana Health in the fourth quarter valued at $40,000. Covestor Ltd grew its holdings in shares of Astrana Health by 210.6% during the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after purchasing an additional 2,192 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares in the last quarter. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.